期刊文献+

Apoptin对人膀胱癌裸鼠皮下移植瘤的抑瘤作用研究 被引量:2

Inhibitory effects of Apoptin on the human bladder carcinoma transplanted subcutaneously in athymic mice
下载PDF
导出
摘要 目的探讨Apoptin质粒对人膀胱癌裸鼠皮下移植瘤的抑瘤作用。方法皮下注射T24细胞,建立裸鼠移植瘤模型,于肿瘤直径0.5cm大小时,多点注射脂质体包裹质粒pApoptin-EGFP,设立空质粒组、生理盐水组作为对照组,观察裸鼠肿瘤生长情况;5周后处死,绘制肿瘤生长曲线,计算抑瘤率,肿瘤组织石蜡包埋,常规切片,TUNEL法检测移植瘤凋亡情况。结果成功建立移植瘤模型,注射脂质体包裹pApoptin-EGFP质粒能明显抑制移植瘤生长;TUNEL检测凋亡率为(23.24±6.12)%,与对照组相比,差异有统计学意义(P<0.01)。结论Apoptin通过诱导凋亡能明显抑制人膀胱癌裸鼠皮下移植瘤生长。 Objective To investigate the antitumor efficacy of intratumoral administration of plasmid expressing Apoptin in athymie mouse T24 bladder tumor exnograft models grafted subcutaneously. Methods Established athymie mouse human bladder tumor transplantation tumor modelby injeeting T24 eells subeutaneously; To observe the growth of athymie mouse transplantation tumor,when tumor diameter was about 0.5cm,Apoptin-EGFP plasmid pareled with liposome injeeted in it, empty plasmid group and physiologieal saline group were established as control groups,The tumor weight was measured and caleulated eontinually, The miee were killed five weeks later, tumor suppression rate was evaluated and the apoptosis index of eells was deteeted by in situ TUNEL. Results Established athymie mouse exnograft tumor model sueeessfully, the Apoptin-EGFP group eould inhibit the growth of tumor obviously eontrasted to the eontrols,the apoptosis rate was (23.24±6.12)%. Conclusion Apoptin eould inhibit obviously the growth of athymie mouse human T24 bladder eareinoma transplantation tumor by indueing apoptosis.
出处 《重庆医学》 CAS CSCD 2008年第9期940-941,I0001,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(30571864)。
关键词 APOPTIN T24 膀胱肿瘤 移植瘤 凋亡 apoptin T24 bladder tumor exnograft tumor apoptosis
  • 相关文献

参考文献8

  • 1Kooistra K, Zhang YH, Noteborn MH. Viral elements sense tumorigenic processes: proaching selective cancer therapy[J]. Mini Rev Med Chem,2007,7(11) :1155
  • 2李忠俊,滕本秀,程绍钧,张青,胡云.^(131)I-抗-VEGF McAb荷瘤膀胱癌裸鼠放射免疫显像的实验研究[J].重庆医学,2005,34(8):1123-1124. 被引量:1
  • 3Zhang YH, Leliveld SR, Kooistra K, et al. Recombinant Apoptin multimers kill tumor cells but are non-toxic and epitope-shielded in a normal-cell-specific fashion[J]. Exp Cell Res, 2003,289 : 36
  • 4Pietern AM, ven der Eb MM, rademaker HJ. Specific tumor killing with adenovirus vectors containing the Apoptin gene[J]. Gene Ther, 1999; 6 (5) : 882
  • 5Olijslagers SJ, Zhang YH, Backendorf C, et al. Additive cytotoxic effect of apoptin and chemotherapeutic agents paclitaxel and etoposide on human tumour cells[J]. Basic Clin Pharmacol Toxicol, 2007,100 (2):127
  • 6Heilman DW,Teodoro JG,Green MR. Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization,apoptosis,and recruitment of the anaphase-promoting complex/cyclosome to PML bodies [J]. J Virol, 2006,80(15):7535
  • 7Danen-van Oorschot AAM, Zhang YH, Leliveld SR, et al. Importance of nuclear localization of Apoptin for tumorspecific induction of apoptosis[J]. Biol Chem, 2003,278:27729
  • 8Maddika S,Bay GH, Kroczak TJ, et al. Akt is transferred to the nucleus of ceils treated with apoptin,and it participates in apoptin-induced cell death[J]. Cell Prolif,2007, 40(6) :835

二级参考文献11

  • 1Folkman J. Tumor angiogenesis: therapeutic implications [J]. N Engl J Med,1971,285:82.
  • 2Folkman J, Shing Y. Angiogenesis[J]. J Biol Chem,1992,267:10931.
  • 3Asano M, Yukita A, Matsumoto T, et al. An anti-human VEGF monoclonal antibody, MV833, that exhibits potent anti-tumor activity in vivo[J].Hybridoma, 1998,17:185.
  • 4Asano M, Yukita A, Suzuki H. Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor[J]. Jpn J Cancer Res,1999,90:93.
  • 5Kanai T, Konno H, Tanaka T, et al. Anti-tumor and anti-metastatic effects of human-vascular-endothelialgrowth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice[J]. Int J Cancer, 1998,77: 933.
  • 6Luo JC, Toyoda M, Shibuya M. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody[J]. Cancer Res,1998,58:2594.
  • 7Pham CD, Roberts TP, van-Bruggen N. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor[J]. Cancer Invest, 1998,16:225.
  • 8Presta LG, Chen H, O'Connor SJ, et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders[J]. Cancer Res, 1997,57:4593.
  • 9李忠俊,程绍钧.人浸润性膀胱癌裸鼠移植瘤模型的建立及其VEGF的表达[J].第三军医大学学报,2000,22(11):1062-1064. 被引量:10
  • 10李忠俊,程绍钧,滕本秀.^(131)I-抗VEGF McAb的制备及其体外免疫结合活性鉴定[J].第三军医大学学报,2001,23(7):864-868. 被引量:3

同被引文献18

  • 1金正均.合并用药中的相加[J].中国药理学报,1980,1:70-73.
  • 2Kebebew E,Reiff E,Duh QY,et al.Extent of disease at presentation and outcome for adrenocortical carcinoma:have we made progress?[J].World J Surg,2006,30(5):872.
  • 3Leibovitz A,Mc Combs WM,Johnston D,et al.New human cancer cell culture lines SW-13,small-cell carcinoma of the adrenal cortex[J].J Natl Cancer Inst,1973,51(2):691.
  • 4Tritos NA,Cushing GW,Heatley G,et al.Clinical features and prognostic factors associated with adrenocortical carcinoma:Lahey clinic medical center experience[J].Am Surg,2000,66(1):73.
  • 5Xiao XR,Ye LY,Shi LX,et al.Diagnosis and treatment of adrenal tumours:a review of 35 years′ experience[J].Br J Urol,1998,82(2):199.
  • 6Andrews P A, Howell S B. Cellular pharmacology of cisplatin:perspectives on mechanisms of acquired resistance [ J ] . CancerCells,1990,2:35 -43.
  • 7Jordan P,Carmo - Fonseca M. Molecular mechanisms involved incisplatin cytotoxicity [ J ] . Cell Mol Life Sci, 2000,57 ( 8 - 9 ):1229 - 1235.
  • 8Yamada M, 0f Regan, Brown R, et al. Selective recognition of acisplatin - DNA adduct by human mismatch repair proteins[ J].Nucleic Aci Res,1997,25(3) :491 -496.
  • 9Turchi J J,Henkels K. Human Ku autoantigen binds cisplatin damaged DNA but fails to stimulate human DNA - activatedprotein kinase[ J]. J Biol Chem,1996,271(23) : 13861 - 13867.
  • 10Gong J G,Costanzo A,Yang H Q,et al. The tyrosine kinase c -Abl regulates p73 in apoptotic response to cisplatin - inducedDNA damage [ J ]. Nature, 1999,399 ; 806.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部